RxDoctor Payments Data

Ryan Goodmanson, DO

Orthopaedic Surgery · Seattle, WANPI 1053726000

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $75,387 of the $124,921 with a category attached, or 60.3%. 26 manufacturers reported payments, led by Stryker at 38.5% of the total. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$124,921in general payments, 2019–2025

Across 265 payments — averaging $471.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$48K
  • Kuros Biosciences USA, Inc$26K
  • Life Spine, Inc.$13K
  • Amplify Surgical, Inc.$10K
  • Globus Medical$8K
  • VB Spine LLC$7K
  • plus $13K from 20 others

What the payments were for

  • Consulting fees$75,38760%
  • Speaking & faculty fees$2,5002%
  • Travel & lodging$36,74929%
  • Food & beverage$8,3927%
  • Education$1,6151%
  • Gifts$300%
  • Entertainment$2480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$124,921 in reported general payments places this provider in the 90th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington

Medicare billing

Part B allowed, 2024
$235,293
Medicare patients
149
Services billed
829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib85$2,483
Gabapentin71$629
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$440
Cefadroxil33$273
Cyclobenzaprine Hcl74$213
Methylprednisolone26$170
Ibuprofen18$114
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$114
Prednisone48$106

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →